HomeCompaniesCellbyte

Cellbyte

Copilot for Pharmaceutical Drug Launches

Cellbyte is an AI-driven copilot designed for Pricing & Market Access (P&MA) teams in the pharmaceutical industry. It enables users to perform complex data analyses on clinical, regulatory and pricing-related data and to extract insights from industry documents using natural language queries. By radically reducing the time and effort required for research, Cellbyte transforms drug launch strategies, providing critical answers in seconds. The founders Daniel, Felix and Samuel are serial entrepreneurs with a combined experience of 5+ years in the pharmaceutical industry.
Cellbyte
Founded:2024
Team Size:3
Location:Munich, Germany

Active Founders

Felix Steinbrenner, Founder

3 years of experience in Last Mile Delivery Operations at Glocally (W22) where I was responsible for making sure every parcel arrived on time. Currently building Cellbyte, the AI copilot for Pricing&Market Access in pharma.
Felix Steinbrenner
Felix Steinbrenner
Cellbyte

Company Launches

Hi! We are Daniel, Felix, and Samuel, and we are building Cellbyte.

TL;DR: Cellbyte is the AI-driven copilot designed for Pricing & Market Access (P&MA) teams in pharma.

  • Users can perform complex data analyses on clinical, regulatory, and pricing-related data and extract insights from industry documents using natural language queries.
  • Cellbyte radically reduces the time and effort required for research by answering questions in seconds, which would have usually taken days.
  • Currently, we’re focused on integrating Europe’s biggest markets (EU5) before expanding to the U.S.

Problem:

The global pharmaceutical industry is a $1.5 trillion market, with hundreds of new products authorized every year. However, ensuring that each of these innovations reaches patients at the right price and time is easier said than done. This complex process demands sophisticated go-to-market strategies, where specialized Pricing & Market Access (P&MA) teams play a crucial role.

The challenge: Determining the ideal launch strategy is anything but straightforward. P&MA professionals must navigate vast amounts of data - clinical, pricing, regulatory, HTA (Health Technology Assessment), and more. Accessing this vital, up-to-date information presents several significant hurdles:

  • Resource Drain: The majority of time, money, and effort goes into gathering data, leaving only limited resources for developing the actual strategy.
  • Data Reliability: Ensuring trust in the data often requires painstakingly scrolling through extensive documents in foreign languages. Parlez-vous français?
  • Detail Deficiency: Existing databases often lack the granular detail needed to truly understand individual cases or markets.

Solution:

We launched Cellbyte, an AI copilot where users can enter complex questions in natural language, receiving answers in mere seconds. Every prompt is translated to a database query, and the engine retrieves the correct information from structured and unstructured data and outputs text, tables & graphs accordingly.

This is exciting because Cellbyte can already run calculations within seconds, which would usually take multiple days (including data research).

Asks:

  • Let’s chat if you work in the pharmaceutical industry and know someone who spends too much time on data research.
  • For everyone outside of pharma: any warm introductions would help us out a lot - particularly P&MA & Commercial teams in pharma companies of all sizes
  • If you have experience negotiating and winning deals with pharma companies, please get in touch. We recently launched our first product and are about to enter full Sales mode.